Clinical Trials in Boston

Showing 2961-2980 of 8,503 trials

A Mobile Tai Chi Platform for Fall Prevention and Cognition in Older Adults

NCT05209464

The investigators will assess feasibility and acceptability of the Tele-Tai Chi (TC) intervention; explore changes in clinically relevant outcome measures including: physical activity, self-efficacy, quality of life, cognitive function, balance, gait, and evaluate changes in TC proficiency. To achieve this, the investigators are running a single-arm study for older adults that involves a 12-week home-based Tai Chi intervention. Study participation includes four remote and/or in-person (at Spaulding Rehabilitation Hospital) visits to evaluate study participants (mobility tests and questionnaires).

AgingFall

Spaulding Rehabilitation Hospital8 participantsStarted Oct 2022

Boston, Massachusetts, United States

COMPLETEDPhase 1< 1 mile

A Study of Mavorixafor in Combination With Ibrutinib in Participants With Waldenstrom's Macroglobulinemia (WM) Whose Tumors Express Mutations in MYD88 and CXCR4

NCT04274738

The primary objective of the study is to establish a pharmacologically active dose of mavorixafor in combination with ibrutinib based on pooled safety, clinical response, pharmacokinetic (PK) and pharmacodynamic (PD) data to select the recommended dose for a randomized registrations trial.

Waldenstrom's Macroglobulinemia

X4 Pharmaceuticals16 participantsStarted Apr 2020

Denver, Colorado, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +2 more locations

A Mobile Tai Chi Platform for Fall Prevention and Cognition in Older Adults

A Study of Mavorixafor in Combination With Ibrutinib in Participants With Waldenstrom's Macroglobulinemia (WM) Whose Tumors Express Mutations in MYD88 and CXCR4

Find Trials by Condition in Boston

A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension

A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD)

A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer

Phase 2a MIB-626 vs. Placebo COVID-19

SGI-110 in Combination With Carboplatin in Ovarian Cancer

Neural Mechanisms of Family-Focused Treatment for Youth Depression

A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)

Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629)

Behavioral Interventions to Reduce Heavy Drinking Among MSM in HIV Primary Care

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant

Utilizing Battlefield Acupuncture to Treat Chronic Pain

Study of Clinic-delivered Physical Activity Referrals to Cancer Survivors

Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer

Efficacy and Safety of CUSA-081 in the Restoration of Central Venous Access Device (CVAD) Functionality

SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction

Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Infected With Respiratory Syncytial Virus of the Upper Respiratory Tract

Central Nervous System Disorders Following Hematopoietic Stem Cell Transplantation